Clinical trial

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

NCT03976843

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-12-04

PhasePHASE2

Study timeline

Study start (actual)2019-12-04Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

18F-DCFPyLDRUG

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Lantheuscollaborator

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 BethesdaMaryland, United States1 New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03976843 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.